Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

Introduction: Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products. Areas covered: A versatile Vero cell platform has been developed and utilized to...

Full description

Bibliographic Details
Main Authors: P. Noel Barrett, Sara J. Terpening, Doris Snow, Ronald R. Cobb, Otfried Kistner
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:Expert Review of Vaccines
Subjects:
vero cell
emerging viruses
inactivated whole virus vaccine
rapid development
Online Access:http://dx.doi.org/10.1080/14760584.2017.1357471

Similar Items

Similar Items